|
1
|
Thorp E and Tabas I: Mechanisms and consequences of efferocytosis in advanced atherosclerosis. J Leukoc Biol. 86:1089–1095. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Boada-Romero E, Martinez J, Heckmann BL and Green DR: The clearance of dead cells by efferocytosis. Nat Rev Mol Cell Biol. 21:398–414. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Trahtemberg U and Mevorach D: Apoptotic cells induced signaling for immune homeostasis in macrophages and dendritic cells. Front Immunol. 8:13562017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Segawa K and Nagata S: An apoptotic ‘Eat Me’ Signal: Phosphatidylserine exposure. Trends Cell Biol. 25:639–650. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kourtzelis I, Hajishengallis G and Chavakis T: Phagocytosis of apoptotic cells in resolution of inflammation. Front Immunol. 11:5532020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Freeman SA and Grinstein S: Phagocytosis: Receptors, signal integration and the cytoskeleton. Immunol Rev. 262:193–215. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Doran AC, Yurdagul A Jr and Tabas I: Efferocytosis in health and disease. Nat Rev Immunol. 20:254–267. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Levin R, Grinstein S and Canton J: The life cycle of phagosomes: Formation, maturation and resolution. Immunol Rev. 273:156–179. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF, Park D, Woodson RI, Ostankovich M, Sharma P, et al: Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature. 461:282–286. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lauber K, Bohn E, Krober SM, Xiao YJ, Blumenthal SG, Lindemann RK, Marini P, Wiedig C, Zobywalski A, Baksh S, et al: Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell. 113:717–730. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gude DR, Alvarez SE, Paugh SW, Mitra P, Yu J, Griffiths R, Barbour SE, Milstien S and Spiegel S: Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a ‘come-and-get-me’ signal. FASEB J. 22:2629–2638. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Truman LA, Ford CA, Pasikowska M, Pound JD, Wilkinson SJ, Dumitriu IE, Melville L, Melrose LA, Ogden CA, Nibbs R, et al: CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood. 112:5026–5036. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Peter C, Waibel M, Radu CG, Yang LV, Witte ON, Schulze-Osthoff K, Wesselborg S and Lauber K: Migration to apoptotic ‘find-me’ signals is mediated via the phagocyte receptor G2A. J Biol Chem. 283:5296–5305. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gardai SJ, McPhillips KA, Frasch SC, Janssen WJ, Starefeldt A, Murphy-Ullrich JE, Bratton DL, Oldenborg PA, Michalak M and Henson PM: Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell. 123:321–334. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Appelt U, Sheriff A, Gaipl US, Kalden JR, Voll RE and Herrmann M: Viable, apoptotic and necrotic monocytes expose phosphatidylserine: Cooperative binding of the ligand Annexin V to dying but not viable cells and implications for PS-dependent clearance. Cell Death Differ. 12:194–196. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nagata S, Hanayama R and Kawane K: Autoimmunity and the clearance of dead cells. Cell. 140:619–630. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Geng K, Kumar S, Kimani SG, Kholodovych V, Kasikara C, Mizuno K, Sandiford O, Rameshwar P, Kotenko SV and Birge RB: Requirement of gamma-carboxyglutamic acid modification and phosphatidylserine binding for the activation of Tyro3, Axl and Mertk receptors by growth arrest-specific 6. Front Immunol. 8:15212017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ravichandran KS: Find-me and eat-me signals in apoptotic cell clearance: Progress and conundrums. J Exp Med. 207:1807–1817. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tajbakhsh A, Rezaee M, Kovanen PT and Sahebkar A: Efferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms. Pharmacol Ther. 188:12–25. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yoon KW: Dead cell phagocytosis and innate immune checkpoint. BMB Rep. 50:496–503. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tajbakhsh A, Farahani N, Gheibihayat SM, Mirkhabbaz AM, Savardashtaki A, Hamblin MR and Mirzaei H: Autoantigen-specific immune tolerance in pathological and physiological cell death: Nanotechnology comes into view. Int Immunopharmacol. 90:1071772021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, Jonasdottir A, Jonasdottir A, Sigurdsson A, Baker A, Palsson A, et al: A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science. 316:1491–1493. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Smith JG, Melander O, Lövkvist H, Hedblad B, Engström G, Nilsson P, Carlson J, Berglund G, Norrving B and Lindgren A: Common genetic variants on chromosome 9p21 confers risk of ischemic stroke: A large-scale genetic association study. Circ Cardiovasc Genet. 2:159–164. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kojima Y, Downing K, Kundu R, Miller C, Dewey F, Lancero H, Raaz U, Perisic L, Hedin U, Schadt E, et al: Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis. J Clin Invest. 129:21642019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Leeper NJ, Raiesdana A, Kojima Y, Kundu RK, Cheng H, Maegdefessel L, Toh R, Ahn GO, Ali ZA, Anderson DR, et al: Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation. Arterioscler Thromb Vasc Biol. 33:e1–e10. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Martinho-Dias D, Leite-Moreira A and Castro-Chaves P: Calreticulin in the heart: From embryological development to cardiac pathology. Curr Mol Med. 16:12–22. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cunnington MS and Keavney B: Genetic mechanisms mediating atherosclerosis susceptibility at the chromosome 9p21 locus. Curr Atheroscler Rep. 13:193–201. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bäck M, Yurdagul A Jr, Tabas I, Öörni K and Kovanen PT: Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol. 6:389–406. 2019.PubMed/NCBI
|
|
29
|
Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nuñez G, Schnurr M, et al: NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 464:1357–1361. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tabas I and Bornfeldt KE: Macrophage phenotype and function in different stages of atherosclerosis. Circ Res. 118:653–667. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, et al: Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 377:1119–1131. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tabas I: Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol. 10:36–46. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kojima Y, Volkmer JP, McKenna K, Civelek M, Lusis AJ, Miller CL, Direnzo D, Nanda V, Ye J, Connolly AJ, et al: CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature. 536:86–90. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Martinet W, Schrijvers DM and De Meyer GR: Necrotic cell death in atherosclerosis. Basic Res Cardiol. 106:749–760. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tabas I: 2016 Russell Ross memorial lecture in vascular biology: Molecular-cellular mechanisms in the progression of atherosclerosis. Arterioscler Thromb Vasc Biol. 37:183–189. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Han CZ and Ravichandran KS: Metabolic connections during apoptotic cell engulfment. Cell. 147:1442–1445. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
A-Gonzalez N, Bensinger SJ, Hong C, Beceiro S, Bradley MN, Zelcer N, Deniz J, Ramirez C, Díaz M, Gallardo G, et al: Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity. 31:245–258. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mukundan L, Odegaard JI, Morel CR, Heredia JE, Mwangi JW, Ricardo-Gonzalez RR, Goh YP, Eagle AR, Dunn SE, Awakuni JU, et al: PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance. Nat Med. 15:1266–1272. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Festuccia WT, Pouliot P, Bakan I, Sabatini DM and Laplante M: Myeloid-specific Rictor deletion induces M1 macrophage polarization and potentiates in vivo pro-inflammatory response to lipopolysaccharide. PLoS One. 9:e954322014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Schrijvers DM, De Meyer GR, Kockx MM, Herman AG and Martinet W: Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler Thromb Vasc Biol. 25:1256–1261. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yurdagul A Jr, Subramanian M, Wang X, Crown SB, Ilkayeva OR, Darville L, Kolluru GK, Rymond CC, Gerlach BD, Zheng Z, et al: Macrophage metabolism of apoptotic cell-derived arginine promotes continual efferocytosis and resolution of injury. Cell Metab. 31:518–533.e10. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kimani SG, Geng K, Kasikara C, Kumar S, Sriram G, Wu Y and Birge RB: Contribution of defective PS recognition and efferocytosis to chronic inflammation and autoimmunity. Front Immunol. 5:5662014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cai B, Thorp EB, Doran AC, Sansbury BE, Daemen MJ, Dorweiler B, Spite M, Fredman G and Tabas I: MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis. J Clin Invest. 127:564–568. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ait-Oufella H, Kinugawa K, Zoll J, Simon T, Boddaert J, Heeneman S, Blanc-Brude O, Barateau V, Potteaux S, Merval R, et al: Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice. Circulation. 115:2168–2177. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Schrijvers DM, De Meyer GR, Herman AG and Martinet W: Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability. Cardiovasc Res. 73:470–480. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Virmani R, Burke AP, Kolodgie FD and Farb A: Vulnerable plaque: The pathology of unstable coronary lesions. J Interv Cardiol. 15:439–446. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Pulanco MC, Cosman J, Ho MM, Huynh J, Fing K, Turcu J and Fraser DA: Complement protein C1q enhances macrophage foam cell survival and efferocytosis. J Immunol. 198:472–480. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Marsch E, Theelen TL, Demandt JA, Jeurissen M, van Gink M, Verjans R, Janssen A, Cleutjens JP, Meex SJ, Donners MM, et al: Reversal of hypoxia in murine atherosclerosis prevents necrotic core expansion by enhancing efferocytosis. Arterioscler Thromb Vasc Biol. 34:2545–2553. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Gui Y, Yao S, Yan H, Hu L, Yu C, Gao F, Xi C, Li H, Ye Y and Wang Y: A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice. Cardiovasc Res. 112:502–514. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Salman H, Bergman M, Djaldetti M and Bessler H: Hydrophobic but not hydrophilic statins enhance phagocytosis and decrease apoptosis of human peripheral blood cells in vitro. Biomed Pharmacother. 62:41–45. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ivanova EA, Myasoedova VA, Melnichenko AA and Orekhov AN: Peroxisome proliferator-activated receptor (PPAR) gamma agonists as therapeutic agents for cardiovascular disorders: Focus on atherosclerosis. Curr Pharm Des. 23:1119–1124. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Heo KS, Cushman HJ, Akaike M, Woo CH, Wang X, Qiu X, Fujiwara K and Abe J: ERK5 activation in macrophages promotes efferocytosis and inhibits atherosclerosis. Circulation. 130:180–191. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wang J and Liu P: Effects of ERK5 inhibitors on macrophages efferocytosis and the expression of ProS and Axl. Journal of Jinan University (Natural Science & Medicine Edition). 39:93–98. 2018.(In Chinese).
|
|
54
|
Wan E, Yeap XY, Dehn S, Terry R, Novak M, Zhang S, Iwata S, Han X, Homma S, Drosatos K, et al: Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction. Circ Res. 113:1004–1012. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Fox S, Leitch AE, Duffin R, Haslett C and Rossi AG: Neutrophil apoptosis: Relevance to the innate immune response and inflammatory disease. J Innate Immun. 2:216–227. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Hodge S, Tran HB, Hamon R, Roscioli E, Hodge G, Jersmann H, Ween M, Reynolds PN, Yeung A, Treiberg J and Wilbert S: Nonantibiotic macrolides restore airway macrophage phagocytic function with potential anti-inflammatory effects in chronic lung diseases. Am J Physiol Lung Cell Mol Physiol. 312:L678–Ll687. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lee YJ, Lee SH, Youn YS, Choi JY, Song KS, Cho MS and Kang JL: Preventing cleavage of Mer promotes efferocytosis and suppresses acute lung injury in bleomycin treated mice. Toxicol Appl Pharmacol. 263:61–72. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
McCubbrey AL and Curtis JL: Efferocytosis and lung disease. Chest. 143:1750–1757. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Lareau SC, Fahy B, Meek P and Wang A: Chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med. 199:P1–P2. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Noda N, Matsumoto K, Fukuyama S, Asai Y, Kitajima H, Seki N, Matsunaga Y, Kan-O K, Moriwaki A, Morimoto K, et al: Cigarette smoke impairs phagocytosis of apoptotic neutrophils by alveolar macrophages via inhibition of the histone deacetylase/Rac/CD9 pathways. Int Immunol. 25:643–650. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Krysko O, Vandenabeele P, Krysko DV and Bachert C: Impairment of phagocytosis of apoptotic cells and its role in chronic airway diseases. Apoptosis. 15:1137–1146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Simpson JL, Gibson PG, Yang IA, Upham J, James A, Reynolds PN and Hodge S; AMAZES Study Research Group, : Impaired macrophage phagocytosis in non-eosinophilic asthma. Clin Exp Allergy. 43:29–35. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Stanton BF: Cystic fibrosis. Pediatr Clin North Am. 63:xv2016. View Article : Google Scholar
|
|
64
|
Vandivier RW, Fadok VA, Ogden CA, Hoffmann PR, Brain JD, Accurso FJ, Fisher JH, Greene KE and Henson PM: Impaired clearance of apoptotic cells from cystic fibrosis airways. Chest. 121 (Suppl 3):S892002. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Mishra V, Banga J and Silveyra P: Oxidative stress and cellular pathways of asthma and inflammation: Therapeutic strategies and pharmacological targets. Pharmacol Ther. 181:169–182. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Felton JM, Lucas CD, Dorward DA, Duffin R, Kipari T, Vermeren S, Robb CT, MacLeod KG, Serrels B, Schwarze J, et al: Mer-mediated eosinophil efferocytosis regulates resolution of allergic airway inflammation. J Allergy Clin Immunol. 142:1884–1893.e6. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Freeman GJ, Casasnovas JM, Umetsu DT and DeKruyff RH: TIM genes: A family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol Rev. 235:172–189. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Grabiec AM, Denny N, Doherty JA, Happonen KE, Hankinson J, Connolly E, Fife ME, Fujimori T, Fujino N, Goenka A, et al: Diminished airway macrophage expression of the Axl receptor tyrosine kinase is associated with defective efferocytosis in asthma. J Allergy Clin Immunol. 140:1144–1146.e4. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Aziz M, Matsuda A, Yang WL, Jacob A and Wang P: Milk fat globule-epidermal growth factor-factor 8 attenuates neutrophil infiltration in acute lung injury via modulation of CXCR2. J Immunol. 189:393–402. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Choi JY, Park HJ, Lee YJ, Byun J, Youn YS, Choi JH, Woo SY and Kang JL: Upregulation of Mer receptor tyrosine kinase signaling attenuated lipopolysaccharide-induced lung inflammation. J Pharmacol Exp Ther. 344:447–458. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Hodge S, Hodge G, Jersmann H, Matthews G, Ahern J, Holmes M and Reynolds PN: Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 178:139–148. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Yamaryo T, Oishi K, Yoshimine H, Tsuchihashi Y, Matsushima K and Nagatake T: Fourteen-member macrolides promote the phosphatidylserine receptor-dependent phagocytosis of apoptotic neutrophils by alveolar macrophages. Antimicrob Agents Chemother. 47:48–53. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Hodge S, Hodge G, Brozyna S, Jersmann H, Holmes M and Reynolds PN: Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages. Eur Respir J. 28:486–495. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Xiong Z, Leme AS, Ray P, Shapiro SD and Lee JS: CX3CR1+ lung mononuclear phagocytes spatially confined to the interstitium produce TNF-α and IL-6 and promote cigarette smoke-induced emphysema. J Immunol. 186:3206–3214. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
McColl A, Bournazos S, Franz S, Perretti M, Morgan BP, Haslett C and Dransfield I: Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages. J Immunol. 183:2167–2175. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Zizzo G, Hilliard BA, Monestier M and Cohen PL: Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. J Immunol. 189:3508–3520. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Grégoire M, Uhel F, Lesouhaitier M, Gacouin A, Guirriec M, Mourcin F, Dumontet E, Chalin A, Samson M, Berthelot LL, et al: Impaired efferocytosis and neutrophil extracellular trap clearance by macrophages in ARDS. Eur Respir J. 52:17025902018. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Grabiec AM and Hussell T: The role of airway macrophages in apoptotic cell clearance following acute and chronic lung inflammation. Semin Immunopathol. 38:409–423. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Krenkel O and Tacke F: Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol. 17:306–321. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Bukong TN, Cho Y, Iracheta-Vellve A, Saha B, Lowe P, Adejumo A, Furi I, Ambade A, Gyongyosi B, Catalano D, et al: Abnormal neutrophil traps and impaired efferocytosis contribute to liver injury and sepsis severity after binge alcohol use. J Hepatol. 69:1145–1154. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Horst AK, Tiegs G and Diehl L: Contribution of macrophage efferocytosis to liver homeostasis and disease. Front Immunol. 10:26702019. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Rocco A, Compare D, Angrisani D, Sanduzzi Zamparelli M and Nardone G: Alcoholic disease: Liver and beyond. World J Gastroenterol. 20:14652–14659. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Wang X, Bu HF, Zhong W, Asai A, Zhou Z and Tan XD: MFG-E8 and HMGB1 are involved in the mechanism underlying alcohol-induced impairment of macrophage efferocytosis. Mol Med. 19:170–182. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Roszer T, Menendez-Gutierrez MP, Lefterova MI, Alameda D, Núñez V, Lazar MA, Fischer T and Ricote M: Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor gamma or retinoid X receptor alpha deficiency. J Immunol. 186:621–631. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Tutusaus A, de Gregorio E, Cucarull B, Cristóbal H, Aresté C, Graupera I, Coll M, Colell A, Gausdal G, Lorens JB, et al: A functional role of GAS6/TAM in nonalcoholic steatohepatitis progression implicates AXL as therapeutic target. Cell Mol Gastroenterol Hepatol. 9:349–368. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Ashraf NU and Sheikh TA: Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease. Free Radic Res. 49:1405–1418. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Anwar A, Keating AK, Joung D, Sather S, Kim GK, Sawczyn KK, Brandão L, Henson PM and Graham DK: Mer tyrosine kinase (MerTK) promotes macrophage survival following exposure to oxidative stress. J Leukoc Biol. 86:73–79. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Mridha AR, Wree A, Robertson AAB, Yeh MM, Johnson CD, Van Rooyen DM, Haczeyni F, Teoh NC, Savard C, Ioannou GN, et al: NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J Hepatol. 66:1037–1046. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Liu W, Bai F, Wang H, Liang Y, Du X, Liu C, Cai D, Peng J, Zhong G, Liang X, et al: Tim-4 inhibits NLRP3 inflammasome via the LKB1/AMPKα pathway in macrophages. J Immunol. 203:990–1000. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
El Bassat H, Ziada DH, Hasby EA, Nagy H and Abo Ryia MH: Apoptotic and anti-apoptotic seromarkers for assessment of disease severity of non-alcoholic steatohepatitis. Arab J Gastroenterol. 15:6–11. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
de Alwis NM and Day CP: Non-alcoholic fatty liver disease: The mist gradually clears. J Hepatol. 48 (Suppl 1):S104–S112. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Yao Q, Li S, Li X, Wang F and Tu C: Myricetin modulates macrophage polarization and mitigates liver inflammation and fibrosis in a murine model of nonalcoholic steatohepatitis. Front Med (Lausanne). 7:712020. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Yang M, Liu J, Piao C, Shao J and Du J: ICAM-1 suppresses tumor metastasis by inhibiting macrophage M2 polarization through blockade of efferocytosis. Cell Death Dis. 6:e17802015. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Rantakari P, Patten DA, Valtonen J, Karikoski M, Gerke H, Dawes H, Laurila J, Ohlmeier S, Elima K, Hübscher SG, et al: Stabilin-1 expression defines a subset of macrophages that mediate tissue homeostasis and prevent fibrosis in chronic liver injury. Proc Natl Acad Sci USA. 113:9298–9303. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Llacuna L, Bárcena C, Bellido-Martín L, Fernández L, Stefanovic M, Marí M, García-Ruiz C, Fernández-Checa JC, García de Frutos P and Morales A: Growth arrest-specific protein 6 is hepatoprotective against murine ischemia/reperfusion injury. Hepatology. 52:1371–1379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Lafdil F, Chobert MN, Deveaux V, Zafrani ES, Mavier P, Nakano T, Laperche Y and Brouillet A: Growth arrest-specific protein 6 deficiency impairs liver tissue repair after acute toxic hepatitis in mice. J Hepatol. 51:55–66. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Caberoy NB, Alvarado G, Bigcas JL and Li W: Galectin-3 is a new MerTK-specific eat-me signal. J Cell Physiol. 227:401–407. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Triantafyllou E, Pop OT, Possamai LA, Wilhelm A, Liaskou E, Singanayagam A, Bernsmeier C, Khamri W, Petts G, Dargue R, et al: MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure. Gut. 67:333–347. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Otani A, Ishihara S, Aziz MM, Oshima N, Mishima Y, Moriyama I, Yuki T, Amano Y, Ansary MM and Kinoshita Y: Intrarectal administration of milk fat globule epidermal growth factor-8 protein ameliorates murine experimental colitis. Int J Mol Med. 29:349–356. 2012.PubMed/NCBI
|
|
100
|
Rothlin CV, Leighton JA and Ghosh S: Tyro3, Axl and Mertk receptor signaling in inflammatory bowel disease and colitis-associated cancer. Inflamm Bowel Dis. 20:1472–1480. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Bosurgi L, Bernink JH, Delgado Cuevas V, Gagliani N, Joannas L, Schmid ET, Booth CJ, Ghosh S and Rothlin CV: Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer. Proc Natl Acad Sci USA. 110:13091–13096. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Steiner CA, Rodansky ES, Johnson LA, Berinstein JA, Cushing KC, Huang S, Spence JR and Higgins PDR: AXL is a potential target for the treatment of intestinal fibrosis. Inflamm Bowel Dis. 27:303–316. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Akitake-Kawano R, Seno H, Nakatsuji M, Kimura Y, Nakanishi Y, Yoshioka T, Kanda K, Kawada M, Kawada K, Sakai Y and Chiba T: Inhibitory role of Gas6 in intestinal tumorigenesis. Carcinogenesis. 34:1567–1574. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Shankman LS, Fleury ST, Evans WB, Penberthy KK, Arandjelovic S, Blumberg RS, Agaisse H and Ravichandran KS: Efferocytosis by Paneth cells within the intestine. Curr Biol. 31:2469–2476.e5. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Fuchs Y and Steller H: Programmed cell death in animal development and disease. Cell. 147:742–758. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Biermann M, Maueröder C, Brauner JM, Chaurio R, Janko C, Herrmann M and Muñoz LE: Surface code-biophysical signals for apoptotic cell clearance. Phys Biol. 10:0650072013. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Yang F, He Y, Zhai Z and Sun E: Programmed cell death pathways in the pathogenesis of systemic lupus erythematosus. J Immunol Res. 2019:36385622019. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Tajbakhsh A, Rezaee M, Barreto GE, Moallem SA, Henney NC and Sahebkar A: The role of nuclear factors as ‘Find-Me’/alarmin signals and immunostimulation in defective efferocytosis and related disorders. Int Immunopharmacol. 80:1061342020. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Silva MT, do Vale A and dos Santos NM: Secondary necrosis in multicellular animals: An outcome of apoptosis with pathogenic implications. Apoptosis. 13:463–482. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Muñoz LE, Lauber K, Schiller M, Manfredi AA and Herrmann M: The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol. 6:280–289. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Qi N, Liu P, Zhang Y, Wu H, Chen Y and Han D: Development of a spontaneous liver disease resembling autoimmune hepatitis in mice lacking tyro3, axl and mer receptor tyrosine kinases. PLoS One. 8:e666042013. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Mills JA: Systemic lupus erythematosus. N Engl J Med. 330:1871–1879. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Yaniv G, Twig G, Shor DB, Furer A, Sherer Y, Mozes O, Komisar O, Slonimsky E, Klang E, Lotan E, et al: A volcanic explosion of autoantibodies in systemic lupus erythematosus: A diversity of 180 different antibodies found in SLE patients. Autoimmun Rev. 14:75–79. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Huang WN, Tso TK, Wu HC, Yang HF and Tsay GJ: Impaired phagocytosis of apoptotic cell material in serologically active clinically quiescent patients with systemic lupus erythematosis. Int J Rheum Dis. 19:1310–1316. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Sakamoto K, Fukushima Y, Ito K, Matsuda M, Nagata S, Minato N and Hattori M: Osteopontin in Spontaneous Germinal Centers inhibits apoptotic cell engulfment and promotes Anti-Nuclear antibody production in Lupus-Prone Mice. J Immunol. 197:2177–2186. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Recarte-Pelz P, Tàssies D, Espinosa G, Hurtado B, Sala N, Cervera R, Reverter JC and de Frutos PG: Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: Correlation with common genetic variants and disease activity. Arthritis Res Ther. 15:R412013. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Lu Q and Lemke G: Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science. 293:306–311. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Rodriguez-Manzanet R, Sanjuan MA, Wu HY, Quintana FJ, Xiao S, Anderson AC, Weiner HL, Green DR and Kuchroo VK: T and B cell hyperactivity and autoimmunity associated with niche-specific defects in apoptotic body clearance in TIM-4-deficient mice. Proc Natl Acad Sci USA. 107:8706–8711. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Xiao S, Brooks CR, Zhu C, Wu C, Sweere JM, Petecka S, Yeste A, Quintana FJ, Ichimura T, Sobel RA, et al: Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant mice. Proc Natl Acad Sci USA. 109:12105–12110. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Ramirez-Ortiz ZG, Pendergraft WF III, Prasad A, Byrne MH, Iram T, Blanchette CJ, Luster AD, Hacohen N, El Khoury J and Means TK: The scavenger receptor SCARF1 mediates the clearance of apoptotic cells and prevents autoimmunity. Nat Immunol. 14:917–926. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Tian L, Choi SC, Murakami Y, Allen J, Morse HC III, Qi CF, Krzewski K and Coligan JE: p85α recruitment by the CD300f phosphatidylserine receptor mediates apoptotic cell clearance required for autoimmunity suppression. Nat Commun. 5:31462014. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Waterborg CEJ, Koenders MI, van Lent PLEM, van der Kraan PM and van de Loo FAJ: Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis. PLoS One. 13:e02059022018. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Park MC, Kwon YJ, Chung SJ, Park YB and Lee SK: Liver X receptor agonist prevents the evolution of collagen-induced arthritis in mice. Rheumatology (Oxford). 49:882–890. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Huang Y, Fu X, Lyu X, Xu Z, He Z, Zhang Y, Zeng Y, He F and Huang G: Activation of LXR attenuates collagen-induced arthritis via suppressing BLyS production. Clin Immunol. 161:339–347. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Zhu X, Chen F, Lu K, Wei A, Jiang Q and Cao W: PPARγ preservation via promoter demethylation alleviates osteoarthritis in mice. Ann Rheum Dis. 78:1420–1429. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Noble JA: Immunogenetics of type 1 diabetes: A comprehensive review. J Autoimmun. 64:101–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Rodriguez-Fernandez S, Pujol-Autonell I, Brianso F, Perna-Barrull D, Cano-Sarabia M, Garcia-Jimeno S, Villalba A, Sanchez A, Aguilera E, Vazquez F, et al: Phosphatidylserine-liposomes promote tolerogenic features on dendritic cells in human type 1 diabetes by apoptotic mimicry. Front Immunol. 9:2532018. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Khanna S, Biswas S, Shang Y, Collard E, Azad A, Kauh C, Bhasker V, Gordillo GM, Sen CK and Roy S: Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS One. 5:e95392010. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Das A, Ghatak S, Sinha M, Chaffee S, Ahmed NS, Parinandi NL, Wohleb ES, Sheridan JF, Sen CK and Roy S: Correction of MFG-E8 resolves inflammation and promotes cutaneous wound healing in diabetes. J Immunol. 196:5089–5100. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Witas R, Peck AB, Ambrus JL and Nguyen CQ: Sjogren's syndrome and TAM receptors: A possible contribution to disease onset. J Immunol Res. 2019:48137952019. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Chen CH, Chen HC, Chang CC, Peng YJ, Lee CH, Shieh YS, Hung YJ and Lin YF: Growth arrest-specific 6 protein in patients with Sjögren syndrome: Determination of the plasma level and expression in the labial salivary gland. PLoS One. 10:e01399552015. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Qin B, Wang J, Ma N, Yang M, Fu H, Liang Y, Huang F, Yang Z and Zhong R: The association of Tyro3/Axl/Mer signaling with inflammatory response, disease activity in patients with primary Sjögren's syndrome. Joint Bone Spine. 82:258–263. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Lauber K, Keppeler H, Munoz LE, Koppe U, Schröder K, Yamaguchi H, Krönke G, Uderhardt S, Wesselborg S, Belka C, et al: Milk fat globule-EGF factor 8 mediates the enhancement of apoptotic cell clearance by glucocorticoids. Cell Death Differ. 20:1230–1240. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Zagórska A, Través PG, Lew ED, Dransfield I and Lemke G: Diversification of TAM receptor tyrosine kinase function. Nat Immunol. 15:920–928. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Elliott MR and Ravichandran KS: Clearance of apoptotic cells: Implications in health and disease. J Cell Biol. 189:1059–1070. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Maderna P, Yona S, Perretti M and Godson C: Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac(2–26). J Immunol. 174:3727–3733. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Majai G, Sarang Z, Csomós K, Zahuczky G and Fésüs L: PPARgamma-dependent regulation of human macrophages in phagocytosis of apoptotic cells. Eur J Immunol. 37:1343–1354. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Kawano M and Nagata S: Efferocytosis and autoimmune disease. Int Immunol. 30:551–558. 2018.PubMed/NCBI
|
|
139
|
Tait AS, Butts CL and Sternberg EM: The role of glucocorticoids and progestins in inflammatory, autoimmune and infectious disease. J Leukoc Biol. 84:924–931. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Wolf SA, Boddeke HW and Kettenmann H: Microglia in physiology and disease. Annu Rev Physiol. 79:619–643. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Radi E, Formichi P, Battisti C and Federico A: Apoptosis and oxidative stress in neurodegenerative diseases. J Alzheimers Dis. 42 (Suppl 3):S125–S152. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Fuller AD and Eldik LJ: MFG-E8 regulates microglial phagocytosis of apoptotic neurons. J Neuroimmune Pharmacol. 3:246–256. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Ji R, Tian S, Lu HJ and Lu Q, Zheng Y, Wang X, Ding J, Li Q and Lu Q: TAM receptors affect adult brain neurogenesis by negative regulation of microglial cell activation. J Immunol. 191:6165–6177. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Ramachandran G and Udgaonkar JB: Mechanistic studies unravel the complexity inherent in tau aggregation leading to Alzheimer's disease and the tauopathies. Biochemistry. 52:4107–4126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Zheng Y, Wang Q, Xiao B, Lu Q, Wang Y and Wang X: Involvement of receptor tyrosine kinase Tyro3 in amyloidogenic APP processing and β-amyloid deposition in Alzheimer's disease models. PLoS One. 7:e390352012. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Fricker M, Neher JJ, Zhao JW, Théry C, Tolkovsky AM and Brown GC: MFG-E8 mediates primary phagocytosis of viable neurons during neuroinflammation. J Neurosci. 32:2657–2666. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Xu X, Zhang A, Zhu Y, He W, Di W, Fang Y and Shi X: MFG-E8 reverses microglial-induced neurotoxic astrocyte (A1) via NF-κB and PI3K-Akt pathways. J Cell Physiol. 234:904–914. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Shi X, Cai X, Di W, Li J, Xu X, Zhang A, Qi W, Zhou Z and Fang Y: MFG-E8 selectively inhibited Aβ-induced microglial M1 polarization via NF-κB and PI3K-Akt pathways. Mol Neurobiol. 54:7777–7788. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Xu X, Cai X, Zhu Y, He W, Wu Q, Shi X, Fang Y and Pei Z: MFG-E8 inhibits Aβ-induced microglial production of cathelicidin-related antimicrobial peptide: A suitable target against Alzheimer's disease. Cell Immunol. 331:59–66. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Kalia LV, Kalia SK, McLean PJ, Lozano AM and Lang AE: α-Synuclein oligomers and clinical implications for Parkinson disease. Ann Neurol. 73:155–169. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Gardai SJ, Mao W, Schüle B, Babcock M, Schoebel S, Lorenzana C, Alexander J, Kim S, Glick H, Hilton K, et al: Elevated alpha-synuclein impairs innate immune cell function and provides a potential peripheral biomarker for Parkinson's disease. PLoS One. 8:e716342013. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM, Huang D, Kidd G, Dombrowski S, Dutta R, et al: Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci. 9:917–924. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Depboylu C, Schäfer MK, Arias-Carrión O, Oertel WH, Weihe E and Höglinger GU: Possible involvement of complement factor C1q in the clearance of extracellular neuromelanin from the substantia nigra in Parkinson disease. J Neuropathol Exp Neurol. 70:125–132. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Michelakakis H, Xiromerisiou G, Dardiotis E, Bozi M, Vassilatis D, Kountra PM, Patramani G, Moraitou M, Papadimitriou D, Stamboulis E, et al: Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson's disease. Mov Disord. 27:400–405. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, Xing Y, Lubischer JL, Krieg PA, Krupenko SA, et al: A transcriptome database for astrocytes, neurons and oligodendrocytes: A new resource for understanding brain development and function. J Neurosci. 28:264–278. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
156
|
Fourgeaud L, Través PG, Tufail Y, Leal-Bailey H, Lew ED, Burrola PG, Callaway P, Zagórska A, Rothlin CV, Nimmerjahn A and Lemke G: TAM receptors regulate multiple features of microglial physiology. Nature. 532:240–244. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Nakashima Y, Miyagi-Shiohira C, Noguchi H and Omasa T: The healing effect of human milk fat Globule-EGF factor 8 protein (MFG-E8) in A rat model of Parkinson's disease. Brain Sci. 8:1672018. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Ghahremani Piraghaj M, Soudi S, Ghanbarian H, Bolandi Z, Namaki S and Hashemi SM: Effect of efferocytosis of apoptotic mesenchymal stem cells (MSCs) on C57BL/6 peritoneal macrophages function. Life Sci. 212:203–212. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Werfel TA and Cook RS: Efferocytosis in the tumor microenvironment. Semin Immunopathol. 40:545–554. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Jetten N, Verbruggen S, Gijbels MJ, Post MJ, De Winther MP and Donners MM: Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo. Angiogenesis. 17:109–118. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Han Q, Shi H and Liu F: CD163(+) M2-type tumor-associated macrophage support the suppression of tumor-infiltrating T cells in osteosarcoma. Int Immunopharmacol. 34:101–106. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Finkernagel F, Reinartz S, Lieber S, Adhikary T, Wortmann A, Hoffmann N, Bieringer T, Nist A, Stiewe T, Jansen JM, et al: The transcriptional signature of human ovarian carcinoma macrophages is associated with extracellular matrix reorganization. Oncotarget. 7:75339–75352. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Yeh HW, Chiang CF, Chen PH, Su CC, Wu YC, Chou L, Huang RY, Liu SY and Shieh YS: Axl involved in mineral trioxide aggregate induces macrophage polarization. J Endod. 44:1542–1548. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Graham DK, Salzberg DB, Kurtzberg J, Sather S, Matsushima GK, Keating AK, Liang X, Lovell MA, Williams SA, Dawson TL, et al: Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemia. Clin Cancer Res. 12:2662–2669. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Wang Y, Moncayo G, Morin P Jr, Xue G, Grzmil M, Lino MM, Clément-Schatlo V, Frank S, Merlo A and Hemmings BA: Mer receptor tyrosine kinase promotes invasion and survival in glioblastoma multiforme. Oncogene. 32:872–882. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Schlegel J, Sambade MJ, Sather S, Moschos SJ, Tan AC, Winges A, DeRyckere D, Carson CC, Trembath DG, Tentler JJ, et al: MERTK receptor tyrosine kinase is a therapeutic target in melanoma. J Clin Invest. 123:2257–2267. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Myers KV, Amend SR and Pienta KJ: Targeting Tyro3, Axl and MerTK (TAM receptors): Implications for macrophages in the tumor microenvironment. Mol Cancer. 18:942019. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Bondanza A, Zimmermann VS, Rovere-Querini P, Turnay J, Dumitriu IE, Stach CM, Voll RE, Gaipl US, Bertling W, Pöschl E, et al: Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo. J Exp Med. 200:1157–1165. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Linger RM, Keating AK, Earp HS and Graham DK: Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors. Expert Opin Ther Targets. 14:1073–1090. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Sawabu T, Seno H, Kawashima T, Fukuda A, Uenoyama Y, Kawada M, Kanda N, Sekikawa A, Fukui H, Yanagita M, et al: Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway. Mol Carcinog. 46:155–164. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Lee-Sherick AB, Eisenman KM, Sather S, McGranahan A, Armistead PM, McGary CS, Hunsucker SA, Schlegel J, Martinson H, Cannon C, et al: Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia. Oncogene. 32:5359–5368. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Brightwell RM, Grzankowski KS, Lele S, Eng K, Arshad M, Chen H and Odunsi K: The CD47 ‘don't eat me signal’ is highly expressed in human ovarian cancer. Gynecol Oncol. 143:393–397. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Willingham SB, Volkmer JP, Gentles AJ, Sahoo D, Dalerba P, Mitra SS, Wang J, Contreras-Trujillo H, Martin R, Cohen JD, et al: The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci USA. 109:6662–6667. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Chao MP, Alizadeh AA, Tang C, Myklebust JH, Varghese B, Gill S, Jan M, Cha AC, Chan CK, Tan BT, et al: Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma. Cell. 142:699–713. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Liang YY, Schwarzinger I, Simonitsch-Klupp I, Agis H and Oehler R: Impaired efferocytosis by monocytes in multiple myeloma. Oncol Lett. 16:409–416. 2018.PubMed/NCBI
|
|
176
|
Terzić J, Grivennikov S, Karin E and Karin M: Inflammation and colon cancer. Gastroenterology. 138:2101–2114.e5. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Lew DS, Mazzoni F and Finnemann SC: Microglia inhibition delays retinal degeneration due to MerTK phagocytosis receptor deficiency. Front Immunol. 11:14632020. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Jun JI, Kim KH and Lau LF: The matricellular protein CCN1 mediates neutrophil efferocytosis in cutaneous wound healing. Nat Commun. 6:73862015. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Borucki DM, Toutonji A, Couch C, Mallah K, Rohrer B and Tomlinson S: Complement-mediated microglial phagocytosis and pathological changes in the development and degeneration of the visual system. Front Immunol. 11:5668922020. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Bossi F, Tripodo C, Rizzi L, Bulla R, Agostinis C, Guarnotta C, Munaut C, Baldassarre G, Papa G, Zorzet S, et al: C1q as a unique player in angiogenesis with therapeutic implication in wound healing. Proc Natl Acad Sci USA. 111:4209–4214. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Wang J, Wong YK and Liao F: What has traditional Chinese medicine delivered for modern medicine? Expert Rev Mol Med. 20:e42018. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Wei J, Wang J, Ma G and Liu P: Effects of Guanxinkang on efferocytosis of spleen macrophages in LDLR-/-mice. Academic Journal of Shanghai University of Traditional Chinese Medicine. 32:56–61. 2018.(In Chinese).
|
|
183
|
Wang J, Mao M, Deng B and Liu P: Effects of Guanxinkang medicated serum on MerTK expression in RAW264.7 macrophages. Academic Journal of Shanghai University of Traditional Chinese Medicine. 32:45–48. 2018.(In Chinese).
|
|
184
|
Wang J and Liu P: Effects of Guanxinkang and its separate prescriptions on TAM receptor expression in peritoneal macrophages of LDLR−/− atherosclerotic mice. Lishizhen Medicine and Materia Medica Research. 29:2326–2328. 2018.(In Chinese).
|
|
185
|
Susanti E, Ratnawati R, Aulani A and Rudijanto A: Catechins green tea upregulates the expression of ABCA1, ABCG1 and SRB1 in rats induced atherogenic diet. J Appl Pharma Sci. 9:91–97. 2019. View Article : Google Scholar
|
|
186
|
Li XY, Kong LX, Li J, He HX and Zhou YD: Kaempferol suppresses lipid accumulation in macrophages through the downregulation of cluster of differentiation 36 and the upregulation of scavenger receptor class B type I and ATP-binding cassette transporters A1 and G1. Int J Mol Med. 31:331–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Kim MS, Kim DS, Kim HS, Kang SW and Kang YH: Inhibitory effects of luteolin on transendothelial migration of monocytes and formation of lipid-laden macrophages. Nutrition. 28:1044–1054. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Park SH, Kim JL, Lee ES, Han SY, Gong JH, Kang MK and Kang YH: Dietary ellagic acid attenuates oxidized LDL uptake and stimulates cholesterol efflux in murine macrophages. J Nutr. 141:1931–1937. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Guan S, Wang B, Li W, Guan J and Fang X: Effects of berberine on expression of LOX-1 and SR-BI in human macrophage-derived foam cells induced by ox-LDL. Am J Chin Med. 38:1161–1169. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Uto-Kondo H, Ayaori M, Ogura M, Nakaya K, Ito M, Suzuki A, Takiguchi S, Yakushiji E, Terao Y, Ozasa H, et al: Coffee consumption enhances high-density lipoprotein-mediated cholesterol efflux in macrophages. Circ Res. 106:779–787. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Ford HZ, Zeboudj L, Purvis GSD, Ten Bokum A, Zarebski AE, Bull JA, Byrne HM, Myerscough MR and Greaves DR: Efferocytosis perpetuates substance accumulation inside macrophage populations. Proc Biol Sci. 286:201907302019.PubMed/NCBI
|
|
192
|
Dattaroy D, Seth RK, Das S, Alhasson F, Chandrashekaran V, Michelotti G, Fan D, Nagarkatti M, Nagarkatti P, Diehl AM and Chatterjee S: Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activation. Am J Physiol Gastrointest Liver Physiol. 310:G510–525. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Zhang X, Zhao Y, Zhang M, Pang X, Xu J, Kang C, Li M, Zhang C, Zhang Z, Zhang Y, et al: Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PLoS One. 7:e425292012. View Article : Google Scholar : PubMed/NCBI
|
|
194
|
Luo D, Guo Y, Cheng Y, Zhao J, Wang Y and Rong J: Natural product celastrol suppressed macrophage M1 polarization against inflammation in diet-induced obese mice via regulating Nrf2/HO-1, MAP kinase and NF-κB pathways. Aging (Albany NY). 9:2069–2082. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Lai YS, Putra RBDS, Aui SP and Chang KT: M2C polarization by baicalin enhances efferocytosis via upregulation of MERTK receptor. Am J Chin Med. 46:1899–1914. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
196
|
Zhu W, Jin Z, Yu J, Liang J, Yang Q, Li F, Shi X, Zhu X and Zhang X: Baicalin ameliorates experimental inflammatory bowel disease through polarization of macrophages to an M2 phenotype. Int Immunopharmacol. 35:119–126. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Cai Q, Li Y and Pei G: Polysaccharides from Ganoderma lucidum attenuate microglia-mediated neuroinflammation and modulate microglial phagocytosis and behavioural response. J Neuroinflammation. 14:632017. View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Wu TF, Hsu CY, Huang HS, Chou SP and Wu H: Proteomic analysis of pycnogenol effects in RAW 264.7 macrophage reveals induction of cathepsin D expression and enhancement of phagocytosis. J Agric Food Chem. 55:9784–9791. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
199
|
Tong H, Mao D, Zhai M, Zhang Z, Sun G and Jiang G: Macrophage activation induced by the polysaccharides isolated from the roots of Sanguisorba officinalis. Pharm Biol. 53:1511–1515. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Wang H, Wei G, Liu F, Banerjee G, Joshi M, Bligh SW, Shi S, Lian H, Fan H, Gu X and Wang S: Characterization of two homogalacturonan pectins with immunomodulatory activity from green tea. Int J Mol Sci. 15:9963–9978. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Gheibi Hayat SM, Bianconi V, Pirro M and Sahebkar A: Efferocytosis: Molecular mechanisms and pathophysiological perspectives. Immunol Cell Biol. 97:124–133. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
202
|
Holden RM, Hétu MF, Li TY, Ward EC, Couture LE, Herr JE, Christilaw E, Adams MA and Johri AM: Circulating Gas6 is associated with reduced human carotid atherosclerotic plaque burden in high risk cardiac patients. Clin Biochem. 64:6–11. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
203
|
Brophy ML, Dong Y, Tao H, Yancey PG, Song K, Zhang K, Wen A, Wu H, Lee Y, Malovichko MV, et al: Myeloid-specific deletion of epsins 1 and 2 reduces atherosclerosis by preventing LRP-1 downregulation. Circ Res. 124:e6–e19. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
204
|
Ait-Oufella H, Pouresmail V, Simon T, Blanc-Brude O, Kinugawa K, Merval R, Offenstadt G, Lesèche G, Cohen PL, Tedgui A and Mallat Z: Defective mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis. Arterioscler Thromb Vasc Biol. 28:1429–1431. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
205
|
Zhang Y, Wang Y, Zhou D, Zhang LS, Deng FX, Shu S, Wang LJ, Wu Y, Guo N, Zhou J and Yuan ZY: Angiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT1R/ROS/p38 MAPK/ADAM17 pathway. Am J Physiol Cell Physiol. 317:C776–C787. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
206
|
Thorp E, Cui D, Schrijvers DM, Kuriakose G and Tabas I: Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe−/− mice. Arterioscler Thromb Vasc Biol. 28:1421–1428. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
207
|
Boisvert WA, Rose DM, Boullier A, Quehenberger O, Sydlaske A, Johnson KA, Curtiss LK and Terkeltaub R: Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size. Arterioscler Thromb Vasc Biol. 26:563–569. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
208
|
Gong S, Xu Z, Liu Y, Xing L, Ma J, Yu C, Liu X, Jia X, Xie R and Sui M: Plasma sMer, sAxl and GAS6 levels correlate with disease activity and severity in lupus nephritis. Eur J Clin Invest. 49:e130642019. View Article : Google Scholar : PubMed/NCBI
|
|
209
|
Tworkoski KA, Platt JT, Bacchiocchi A, Bosenberg M, Boggon TJ and Stern DF: MERTK controls melanoma cell migration and survival and differentially regulates cell behavior relative to AXL. Pigment Cell Melanoma Res. 26:527–541. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
210
|
Demarest SJ, Gardner J, Vendel MC, Ailor E, Szak S, Huang F, Doern A, Tan X, Yang W, Grueneberg DA, et al: Evaluation of Tyro3 expression, Gas6-mediated Akt phosphorylation and the impact of anti-Tyro3 antibodies in melanoma cell lines. Biochemistry. 52:3102–3118. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
211
|
Xie S, Li Y, Li X, Wang L, Yang N, Wang Y and Wei H: Mer receptor tyrosine kinase is frequently overexpressed in human non-small cell lung cancer, confirming resistance to erlotinib. Oncotarget. 6:9206–9219. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
212
|
Walport MJ, Davies KA and Botto M: C1q and systemic lupus erythematosus. Immunobiology. 199:265–285. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
213
|
Huang W, Wu J, Yang H, Xiong Y, Jiang R, Cui T and Ye D: Milk fat globule-EGF factor 8 suppresses the aberrant immune response of systemic lupus erythematosus-derived neutrophils and associated tissue damage. Cell Death Differ. 24:263–275. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
214
|
Zhu H, Sun X, Zhu L, Hu F, Shi L, Li Z and Su Y: The expression and clinical significance of different forms of Mer receptor tyrosine kinase in systemic lupus erythematosus. J Immunol Res. 2014:4318962014. View Article : Google Scholar : PubMed/NCBI
|
|
215
|
Bertolaccini ML, Sanna G, Ralhan S, Gennari LC, Merrill JT, Khamashta MA and Hughes GR: Antibodies directed to protein S in patients with systemic lupus erythematosus: Prevalence and clinical significance. Thromb Haemost. 90:636–641. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
216
|
Peng Y and Elkon KB: Autoimmunity in MFG-E8-deficient mice is associated with altered trafficking and enhanced cross-presentation of apoptotic cell antigens. J Clin Invest. 121:2221–2241. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
217
|
Avilla E, Guarino V, Visciano C, Liotti F, Svelto M, Krishnamoorthy G, Franco R and Melillo RM: Activation of TYRO3/AXL tyrosine kinase receptors in thyroid cancer. Cancer Res. 71:1792–1804. 2011. View Article : Google Scholar : PubMed/NCBI
|
